Investor Presentaiton
PHARMACEUTICALS
PROMOMEDⓇ
PRO
100000
60008
+
7 000 000
PACKAGES PER MONTH
uvex
<<Promomed» Group of Companies is one of the
leaders of the domestic pharmaceutical industry,
an active participant in the system of ensuring
national drug safety. The company develops,
manufactures and promotes modern medicines,
focusing its efforts on increasing the effectiveness
and improving the safety profile of the treatment
of the most important, including socially significant
diseases, including cancer.
Due to a powerful biotechnological platform - JSC
«Biokhimik» (joined the group in 2015), working in
full compliance with GMP standards, the company
is able to quickly and efficiently develop and
produce any innovative drugs. In March 2023 the
grand opening of the plant for the production of
active pharmaceutical substances took place with
the participation of the President of the Russian
Federation Vladimir Putin.
200
NAMES OF MEDICINES
The company implements a full cycle of
pharmaceutical production: from the molecule to
the finished dosage form. The production complex
of <<Biokhimik>> has six workshops, its own R&D
center equipped with modern European-class
equipment, which allows developing not only
generics, but also original drugs, the share of which
is now about 30% of the products being developed.
ЭСПЕРАВИР
Претивовирусное предство
200
40 WICK
PROMOMED
ЭСПЕРАВИР
>190
NEW DRUGS
IN DEVELOPMENT
20040
REPUBLIC OF MORDOVIA
23View entire presentation